1. CXCL10/IP‐10, an early biomarker for late sequelae in DRESS?. (1st November 2020) Authors: Bellón, T.; Kardaun, S.H. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CXCL10/IP‐10, an early biomarker for late sequelae in DRESS?. (27th April 2020) Authors: Bellón, T.; Kardaun, S.H. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HMGB1 expression in SJS/TEN sera and skin. (1st July 2019) Authors: Carr, D.F.; Wang, C.‐W.; Bellón, T.; Ressel, L.; Nwikue, G.; Shrivastava, V.; Bergfeld, W.; Jorgensen, A.L.; Chung, W.‐H.; Pirmohamed, M. Journal: British journal of dermatology Issue: Volume 181:Number 1(2019) Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment. Issue 3 (19th January 2018) Authors: Cabañas, R.; Calderón, O.; Ramírez, E.; Fiandor, A.; Caballero, T.; Heredia, R.; Herranz, P.; Madero, R.; Quirce, S.; Bellón, T. Journal: Clinical & experimental allergy Issue: Volume 48:Issue 3(2018) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Serum and blister‐fluid elevation and decreased epidermal content of high‐mobility group box 1 protein in drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis. (1st July 2019) Authors: Carr, D.F.; Wang, C.‐W.; Bellón, T.; Ressel, L.; Nwikue, G.; Shrivastava, V.; Bergfeld, W.; Jorgensen, A.L.; Chung, W.‐H.; Pirmohamed, M. Journal: British journal of dermatology Issue: Volume 181:Number 1(2019) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Serum and blister‐fluid elevation and decreased epidermal content of high‐mobility group box 1 protein in drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis. (26th March 2019) Authors: Carr, D.F.; Wang, C.‐W.; Bellón, T.; Ressel, L.; Nwikue, G.; Shrivastava, V.; Bergfeld, W.; Jorgensen, A.L.; Chung, W.‐H.; Pirmohamed, M. Journal: British journal of dermatology Issue: Volume 181:Number 1(2019) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Serum and blister‐fluid elevation and decreased epidermal content of high‐mobility group box 1 protein in drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis4. (26th March 2019) Authors: Carr, D.F.; Wang, C.‐W.; Bellón, T.; Ressel, L.; Nwikue, G.; Shrivastava, V.; Bergfeld, W.; Jorgensen, A.L.; Chung, W.‐H.; Pirmohamed, M. Journal: British journal of dermatology Issue: Volume 181:Number 1(2019) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Two cases of overlap severe cutaneous adverse reactions to benznidazole treatment for asymptomatic Chagas disease in a nonendemic country. (1st September 2016) Authors: González‐Ramos, J.; Noguera‐Morel, L.; Tong, H.Y.; Ramírez, E.; Ruiz‐Bravo, E.; Bellón, T.; Cabañas, R.; Cachafeiro, L.; Herranz‐Pinto, P. Journal: British journal of dermatology Issue: Volume 175:Number 3(2016) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Two cases of overlap severe cutaneous adverse reactions to benznidazole treatment for asymptomatic Chagas disease in a nonendemic country. (7th April 2016) Authors: González‐Ramos, J.; Noguera‐Morel, L.; Tong, H.Y.; Ramírez, E.; Ruiz‐Bravo, E.; Bellón, T.; Cabañas, R.; Cachafeiro, L.; Herranz‐Pinto, P. Journal: British journal of dermatology Issue: Volume 175:Number 3(2016) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Vemurafenib‐induced toxic epidermal necrolysis: possible cross‐reactivity with other sulfonamide compounds. (1st March 2016) Authors: Bellón, T.; Lerma, V.; González‐Valle, O.; González Herrada, C.; de Abajo, F.J. Journal: British journal of dermatology Issue: Volume 174:Number 3(2016) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗